NC
PCRX icon

Nexthera Capital’s Pacira BioSciences PCRX Stock Holding History

Nexthera Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$6.48M Buy
+149,086
New +$6.33M 5.4% 10
2018
Q3 		– Sell
-566,508
Closed -$18.2M – 62
2018
Q2 		$18.2M Buy
566,508
+87,888
+18% +$3.03M 2.81% 10
2018
Q1 		$14.9M Buy
+478,620
New +$17M 2.46% 14

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Nexthera Capital's PCRX Position: Q2 2019 in Review

Nexthera Capital opened a new position in Pacira BioSciences (PCRX) in Q2 2019: 149,086 shares worth $6.48M. The stake represents 5.4% of the portfolio and ranks #10 among its holdings. This is a return to the name: Nexthera Capital previously reported a position in PCRX as recently as Q2 2018.

Nexthera Capital first reported a position in PCRX in Q1 2018 and has held it in 3 quarters since. The position peaked at $18.2M in Q2 2018. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

  • Nexthera Capital held 149,086 shares of Pacira BioSciences worth $6.48M as of Q2 2019.
  • Pacira BioSciences was a new Nexthera Capital position in Q2 2019.
  • Pacira BioSciences made up 5.4% of Nexthera Capital's portfolio in Q2 2019, its #10 holding.
  • Nexthera Capital first reported a position in Pacira BioSciences in Q1 2018 and has held it in 3 quarters since.
  • Nexthera Capital's Pacira BioSciences position peaked at $18.2M in Q2 2018.
  • 218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.